MONROVIA, February 2 (LINA) - The world’s first large-scale Ebola vaccine trial gets underway in Liberia today, February 2.
The vaccine was first tested in five small phase-one safety trials in Britain, the United States, Switzerland and Mali, involving around 200 healthy volunteers in total.
It is expected that about 30,000 people will participate in the vaccine trial in Liberia.
Ebola has killed about 9,000 people out of 22,092 cases, with the vast majority of deaths and cases in Liberia, Sierra Leone and Guinea, according to the United Nations’ World Health Organization.
LINA